Shopping Cart 0
Cart Subtotal
USD 0

Travel Vaccines Market : Segmented By Composition (Mono Vaccines and Combination Vaccines); by Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies and Others); by Application (Domestic Travel and Outbound Travel) and Region – Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option : NO
Copy Option : No
Download Option: No
Deliverable Format : Excel viewable on the website via username

Excel Only
USD 3000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 7500

Details

Product Overview

A bio-based formulation that is developed to protects humans against infectious diseases caused by bacteria and viruses is known as the vaccine. Vaccines, also known as immunizations, take advantage of our immune system's innate capacity to combat infectious diseases. Travel vaccines are the shots that are given to travelers before visiting any area of the world. These vaccines protect travelers from serious illness and prevent the spread of diseases within and between countries. The body reacts to the vaccine by producing antibodies that will protect a person in the future if one is exposed to the disease. Travel vaccine shots, in addition to a passport, are now needed before embarking on international travel. Health organizations strongly advise visitors traveling to developed or endemic countries to get travel vaccinations. Vaccination guidelines differ from person to person, depending on the tourist's gender, age, and medical background.

Market Highlights

Global Travel Vaccines market is expected to project a notable CAGR of 8.92% in 2030.

Global Travel Vaccines market to surpass USD 13.63 billion by 2030 from USD 5.8 billion in 2020 at a CAGR of 8.92% in the coming years, i.e., 2021-30. The market is estimated to grow on account of rising cases of travel-related diseases such as Hepatitis A & E, typhoid, tetanus, cholera, Japanese encephalitis, diphtheria, meningitis, yellow fever across the globe. Also, mounting investments in the development of more effective vaccines is augmenting the growth of the travel vaccines market. Advancements in technology, increasing government funding and research & development activities are other factors that are contributing to the market growth.

Global Travel Vaccines Market: Segments

Hepatitis A segment to grow with the highest CAGR during 2020-30

Global Travel Vaccines market is segmented by Disease into Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies and Others. It is a viral disease that can be transmitted to other person through direct contact with an infectious person or the ingestion of contaminated food and water. Hepatitis A can cause mild to severe illness

Outbound Travel segment to grow with the highest CAGR during 2020-30

Global Travel Vaccines market is divided by Application into Domestic Travel and Outbound Travel. Outbound Travel segment accounted for the largest revenue share in 2020. Outbound travel refers to traveling to another country. Various travel agencies are present that organize outbound tours. Domestic travel means the traveling between two cities within the same country.

Market Dynamics

Drivers

Rising prevalence of travel-related diseases to bolster growth

Increasing occurrence of travel-related diseases is anticipated to boost the market growth. Traveling is often linked to increased health risks, especially when it comes to infectious diseases. As a result of the increasing occurrence of travel-related diseases, more investments will be made in the global Travel Vaccines Market to produce more effective vaccines.

Government regulations for International Travelers

Government authorization bodies such as the Center for Disease Control and Prevention and the National Health Service have made it mandatory to get travel vaccines. This is attributed to recent surge in inbound tourism to developing countries, which face higher health risks from diseases including swine influenza and Ebola hemorrhagic fever and has been a major driver of the travel vaccines market. In addition, over the last few years, international travel activities have risen immensely due to the growing trend of globalization. This in turn has resulted in a significant demand for travel vaccines.

Restraint

Dearth of skilled workforce

Lack of sufficient skilled workforce for the manufacturing of vaccines is expected to impede the market growth. Furthermore, poor healthcare infrastructure and high cost of travel vaccinations may restrain the market in the coming years.

Global Travel Vaccines Market: Key Players

  • GlaxoSmithKline Pharmaceuticals Limited

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • ALK-Abelló A/S
  • Bavarian Nordic A/S
  • Crucell (Subsidiary of Johnson & Johnson)
  • CSL Limited
  • AstraZeneca PLC
  • Altimmune, Inc.
  • Abbott Laboratories
  • Hoffmann-La Roche, Inc.
  • Other Prominent Players

Global Travel Vaccines Market: Regions

Global Travel Vaccines market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. Global Travel Vaccines market in North America held the largest market share in the year 2020. North America being led by the USA is the dominant one. Large number of companies in the region are developing effective travel vaccines, including a vaccine against varicella. Asia Pacific is an emerging market for travel vaccine market owing to improved healthcare infrastructure and increasing healthcare expenditure by government.

Global Travel Vaccines Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Global Travel Vaccines Market report also contains analysis on:

Travel Vaccines Market Segments:

  • By Composition
    • Mono Vaccines
    • Combination Vaccines
  • By Disease
    • Hepatitis A
      • DPT
      • Yellow Fever
      • Typhoid
    • Hepatitis B
      • Measles and Mumps
      • Rabies
    • Others
  • By Application
    • Domestic Travel
    • Outbound Travel
  • Travel Vaccines Market Dynamics
  • Travel Vaccines Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Travel Vaccines Market Report Scope and Segmentation

Frequently Asked Questions

  1. How big is the Travel vaccine market?
  2. What is the Travel Vaccines market growth?
  3. Which segment accounted for the largest Travel Vaccines market share?
  4. Who are the key players in the Travel vaccine market?
  5. What are the factors driving the Travel vaccine market?
READ MORE

Table Of Content

Scope

Contents          

  1. Executive Summary
  2. Global Travel Vaccines Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Travel Vaccines Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Travel Vaccines Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Travel Vaccines Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Composition: Market Share (2020-2030F)
      1. Mono Vaccines, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Combination Vaccines, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Disease: Market Share (2020-2030F)
      1. Hepatitis A, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. DPT, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Yellow Fever, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Typhoid, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Hepatitis B, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      6. Measles and Mumps, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      7. Rabies, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      8. Others, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By Application: Market Share (2020-2030F)
      1. Domestic Travel, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Outbound Travel, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

  1. GlaxoSmithKline Pharmaceuticals Limited
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. Sanofi Pasteur
  3. Merck & Co., Inc.
  4. Novartis AG
  5. Pfizer Inc.
  6. ALK-Abelló A/S
  7. Bavarian Nordic A/S
  8. Crucell (Subsidiary of Johnson & Johnson)
  9. CSL Limited
  10. AstraZeneca PLC
  11. Altimmune, Inc.
  12. Abbott Laboratories
  13. Hoffmann-La Roche, Inc.
  14. Other Prominent Players

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Licence Rights

  • Single User License:

    Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization. The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete/part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

  •  
  • Hard Copy License:

    The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

  •  
  • Corporate User License:

    Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Product Overview

A bio-based formulation that is developed to protects humans against infectious diseases caused by bacteria and viruses is known as the vaccine. Vaccines, also known as immunizations, take advantage of our immune system's innate capacity to combat infectious diseases. Travel vaccines are the shots that are given to travelers before visiting any area of the world. These vaccines protect travelers from serious illness and prevent the spread of diseases within and between countries. The body reacts to the vaccine by producing antibodies that will protect a person in the future if one is exposed to the disease. Travel vaccine shots, in addition to a passport, are now needed before embarking on international travel. Health organizations strongly advise visitors traveling to developed or endemic countries to get travel vaccinations. Vaccination guidelines differ from person to person, depending on the tourist's gender, age, and medical background.

Market Highlights

Global Travel Vaccines market is expected to project a notable CAGR of 8.92% in 2030.

Global Travel Vaccines market to surpass USD 13.63 billion by 2030 from USD 5.8 billion in 2020 at a CAGR of 8.92% in the coming years, i.e., 2021-30. The market is estimated to grow on account of rising cases of travel-related diseases such as Hepatitis A & E, typhoid, tetanus, cholera, Japanese encephalitis, diphtheria, meningitis, yellow fever across the globe. Also, mounting investments in the development of more effective vaccines is augmenting the growth of the travel vaccines market. Advancements in technology, increasing government funding and research & development activities are other factors that are contributing to the market growth.

Global Travel Vaccines Market: Segments

Hepatitis A segment to grow with the highest CAGR during 2020-30

Global Travel Vaccines market is segmented by Disease into Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies and Others. It is a viral disease that can be transmitted to other person through direct contact with an infectious person or the ingestion of contaminated food and water. Hepatitis A can cause mild to severe illness

Outbound Travel segment to grow with the highest CAGR during 2020-30

Global Travel Vaccines market is divided by Application into Domestic Travel and Outbound Travel. Outbound Travel segment accounted for the largest revenue share in 2020. Outbound travel refers to traveling to another country. Various travel agencies are present that organize outbound tours. Domestic travel means the traveling between two cities within the same country.

Market Dynamics

Drivers

Rising prevalence of travel-related diseases to bolster growth

Increasing occurrence of travel-related diseases is anticipated to boost the market growth. Traveling is often linked to increased health risks, especially when it comes to infectious diseases. As a result of the increasing occurrence of travel-related diseases, more investments will be made in the global Travel Vaccines Market to produce more effective vaccines.

Government regulations for International Travelers

Government authorization bodies such as the Center for Disease Control and Prevention and the National Health Service have made it mandatory to get travel vaccines. This is attributed to recent surge in inbound tourism to developing countries, which face higher health risks from diseases including swine influenza and Ebola hemorrhagic fever and has been a major driver of the travel vaccines market. In addition, over the last few years, international travel activities have risen immensely due to the growing trend of globalization. This in turn has resulted in a significant demand for travel vaccines.

Restraint

Dearth of skilled workforce

Lack of sufficient skilled workforce for the manufacturing of vaccines is expected to impede the market growth. Furthermore, poor healthcare infrastructure and high cost of travel vaccinations may restrain the market in the coming years.

Global Travel Vaccines Market: Key Players

  • GlaxoSmithKline Pharmaceuticals Limited

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • ALK-Abelló A/S
  • Bavarian Nordic A/S
  • Crucell (Subsidiary of Johnson & Johnson)
  • CSL Limited
  • AstraZeneca PLC
  • Altimmune, Inc.
  • Abbott Laboratories
  • Hoffmann-La Roche, Inc.
  • Other Prominent Players

Global Travel Vaccines Market: Regions

Global Travel Vaccines market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. Global Travel Vaccines market in North America held the largest market share in the year 2020. North America being led by the USA is the dominant one. Large number of companies in the region are developing effective travel vaccines, including a vaccine against varicella. Asia Pacific is an emerging market for travel vaccine market owing to improved healthcare infrastructure and increasing healthcare expenditure by government.

Global Travel Vaccines Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Global Travel Vaccines Market report also contains analysis on:

Travel Vaccines Market Segments:

  • By Composition
    • Mono Vaccines
    • Combination Vaccines
  • By Disease
    • Hepatitis A
      • DPT
      • Yellow Fever
      • Typhoid
    • Hepatitis B
      • Measles and Mumps
      • Rabies
    • Others
  • By Application
    • Domestic Travel
    • Outbound Travel
  • Travel Vaccines Market Dynamics
  • Travel Vaccines Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Travel Vaccines Market Report Scope and Segmentation

Frequently Asked Questions

  1. How big is the Travel vaccine market?
  2. What is the Travel Vaccines market growth?
  3. Which segment accounted for the largest Travel Vaccines market share?
  4. Who are the key players in the Travel vaccine market?
  5. What are the factors driving the Travel vaccine market?
READ MORE

Scope

Contents          

  1. Executive Summary
  2. Global Travel Vaccines Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Travel Vaccines Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Travel Vaccines Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Travel Vaccines Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Composition: Market Share (2020-2030F)
      1. Mono Vaccines, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Combination Vaccines, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Disease: Market Share (2020-2030F)
      1. Hepatitis A, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. DPT, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Yellow Fever, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Typhoid, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Hepatitis B, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      6. Measles and Mumps, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      7. Rabies, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      8. Others, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By Application: Market Share (2020-2030F)
      1. Domestic Travel, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Outbound Travel, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

  1. GlaxoSmithKline Pharmaceuticals Limited
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. Sanofi Pasteur
  3. Merck & Co., Inc.
  4. Novartis AG
  5. Pfizer Inc.
  6. ALK-Abelló A/S
  7. Bavarian Nordic A/S
  8. Crucell (Subsidiary of Johnson & Johnson)
  9. CSL Limited
  10. AstraZeneca PLC
  11. Altimmune, Inc.
  12. Abbott Laboratories
  13. Hoffmann-La Roche, Inc.
  14. Other Prominent Players

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

  • Single User License:

    Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization. The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete/part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

  •  
  • Hard Copy License:

    The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

  •  
  • Corporate User License:

    Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS